Impact of COVID-19, including patients refraining from seeking medical care, on business activities
First written in FY2021-Q1. 5 of 12 entries say "Materialised", first in FY2021-Q2. Latest entry: FY2024-Q2.
Medical System Network moved to the "Worse" side of this theme in 2020, 2 years before the typical company in this theme (2022).
8 other companies' latest entry also says "Mitigated".
- FY2024-Q2MitigatedAnnual report
「The number of prescriptions processed increased due in part to easing concerns about seeking medical care following the reclassification of COVID-19 as a Category 5 infectious disease, outbreaks of multiple respiratory infections, the use of digital transformation, including the prescription transmission function using LINE, and the effect of follow-up during medication periods.」
The impact on prescriptions processed from patients previously refraining from seeking medical care was mitigated in the community pharmacy business, mainly because concerns about seeking medical care eased following the reclassification of COVID-19 as a Category 5 infectious disease. - FY2024-Q1MitigatedAnnual report
「The number of prescriptions processed increased as concerns about seeking medical care eased following the reclassification of COVID-19 as a Category 5 infectious disease.」
As concerns about seeking medical care eased following the reclassification of COVID-19 as a Category 5 infectious disease, the number of prescriptions processed increased, partially mitigating in the community pharmacy business the previous impact of patients refraining from seeking medical care. - FY2023-Q3MaterialisedAnnual report
「In this business, sales were ¥1,701 million, down 2.9% year on year, and operating loss was ¥55 million, compared with operating profit of ¥7 million in the same period of the previous year, due to a decline in the number of meals provided as a result of the COVID-19 pandemic and a decline in the gross profit margin resulting from higher procurement prices, among other factors.」
The impact of COVID-19 continued in the form of a decline in the number of meals provided, and the food-service business changed from operating profit in the same period of the previous year to an operating loss, compounded by higher purchase prices. - FY2023-Q2MaterialisedAnnual report
「In this business, sales were ¥1,135 million, down 2.7% year on year, and operating loss was ¥33 million, compared with operating profit of ¥1 million in the same period of the previous year, due to a decline in the number of meals provided as a result of the COVID-19 pandemic and a decline in the gross profit margin resulting from higher procurement prices, among other factors.」
The impact of COVID-19 continued during the quarter in the form of a decline in the number of meals provided, and the food-service business changed from operating profit in the same period of the previous year to an operating loss. - FY2022RestatedAnnual report
「The impact of COVID-19 is continuing, and it is difficult to reasonably predict when it will be brought under control. In the community pharmacy business, the number of prescriptions processed has declined compared with before the spread of COVID-19.」
The impact of COVID-19 has continued in the form of declines in prescriptions processed, housing sales activities and the number of meals provided. - FY2022-Q3MaterialisedAnnual report
「Although the number of meals provided declined due to the COVID-19 pandemic, sales were ¥1,752 million, down 6.5% year on year, and operating profit was ¥7 million, compared with an operating loss of ¥2 million in the same period of the previous year, as gross profit improved due in part to a change in suppliers.」
The decline in the number of meals provided due to the impact of COVID-19 continued during the quarter. Meanwhile, the food-service business returned to profitability due to changes in suppliers and other factors. - FY2022-Q2RestatedAnnual report
「In this business, rental income from real estate remained generally solid and orders for construction work increased, while the number of residents in serviced housing for older people struggled to grow because sales activities were restricted due to the impact of COVID-19.」
The impact of COVID-19 has continued in the form of restrictions on sales activities for housing for older people and sluggish growth in the number of residents. - FY2022-Q1RestatedAnnual report
「The number of residents in serviced housing for older people struggled to grow because sales activities were restricted due to the impact of COVID-19. As a result of increased spending on measures against COVID-19 and other factors, revenue was ¥739 million, up 2.3% year on year, and the operating result was an operating loss of ¥2 million, compared with operating profit of ¥6 million in the same period of the previous year.」
The impact of COVID-19 continued during the quarter in the form of restrictions on housing sales activities and increased costs for countermeasures. - FY2021RestatedAnnual report
「The impact of COVID-19 is continuing. In the dispensing pharmacy business, the number of prescriptions processed has declined compared with before the spread of COVID-19. In the rental and facilities-related businesses, sales activities have been restricted and construction orders have been postponed, while the food-service business has seen a decline in the number of meals provided.」
The impact of COVID-19 has continued across multiple businesses, in the form of declines in prescriptions processed, housing sales and construction orders, and the number of meals provided. - FY2021-Q3MaterialisedAnnual report
「During the nine months ended the third quarter, new memberships in the pharmaceutical network business remained generally solid, while the number of prescriptions processed in the dispensing pharmacy business declined, mainly because patients refrained from seeking medical care due to the impact of COVID-19.」
The impact of COVID-19 continued during the quarter in the form of a decline in prescriptions processed because patients refrained from seeking medical care. Postponements of orders for construction work and a decline in the number of meals provided were also reported. - FY2021-Q2MaterialisedAnnual report
「During the six months ended the second quarter, new memberships in the pharmaceutical network business remained solid, while the number of prescriptions processed in the dispensing pharmacy business declined, mainly because patients refrained from seeking medical care due to the impact of COVID-19.」
The impact of COVID-19 continued during the quarter, resulting in a decline in prescriptions processed because patients refrained from seeking medical care, as well as postponements of orders for construction work and a decline in the number of meals provided. There were no material changes to the assumption in the accounting estimates that the impact would continue throughout the fiscal year ending March 2021. - FY2021-Q1First statedAnnual report
「Although the number of long-term prescriptions increased and the average prescription value rose due to patients refraining from seeking medical care and other effects of COVID-19, the number of prescriptions filled declined substantially.」
The impact of COVID-19 was actually felt across multiple businesses, including a substantial decline in prescriptions filled due to patients refraining from seeking medical care, postponement of construction project orders and a decrease in the number of meals provided. The risk factors section states that there were no new risks or material changes.